Nyenta.com

Menu
  • Home
  • Business
  • Financial
  • Books
  • Entertainment
  • Health
  • Education
  • Technology
  • Music
Menu

CCHR: Prescription Psychotropics Fuel America's Addiction and Overdose Crisis
Nyenta.com/10326605

Trending...
  • The Truth About Mesomorphs, Endomorphs & Ectomorphs And Why You Are Not Reaching Weightloss Goals
  • PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
  • Advanced Dentistry of Mohegan Lake Sponsors Charity Golf Event
Prescription Drug Abuse
More than 79 million Americans take psychotropics—millions abuse them, risking overdose—yet the $26 billion psychiatric drug industry's role in the failed war on drugs remains downplayed due to widespread misinformation.

LOS ANGELES - Nyenta -- By CCHR International

The abuse of prescription psychotropic drugs has become a global public health issue and, according to the mental health industry watchdog Citizens Commission on Human Rights International (CCHR), it is a major factor in the failure of America's war on drugs. More than 79 million Americans are prescribed psychotropics—many of which can cause dependence, respiratory depression, seizures, and fatal outcomes, especially when combined with other substances.[1] Since 1999, drug overdoses have killed more than one million people in the U.S. In 2021 alone, 32,537 overdose deaths involved stimulants such as cocaine or prescription psychostimulants—a staggering 5,848% increase from 547 deaths in 1999.[2]

Prescription Abuse Epidemic

The National Center for Drug Abuse Statistics reports that 5.9 million Americans abuse sedatives, 4.9 million abuse stimulants, and 4.8 million abuse benzodiazepines. Two million people—nearly 12% of misusers—are addicted. First-time abusers often start with sedatives or tranquilizers, accounting for more than 32% of initial misuse.[3]

Among stimulant abusers, amphetamine/dextroamphetamine is the most frequently misused (75.8% usage rate), followed by methylphenidate at 24.5%.[4] Both drugs are prescribed for Attention Deficit Hyperactivity Disorder (ADHD)—a behavioral construct, not a medically validated disease, or illness that can be cured by a drug. More than 9.5 million Americans are prescribed ADHD stimulants, including 3.1 million minors.[5]

Adult stimulant prescriptions surged 34% between 2019 and 2022. A JAMA Psychiatry study of 84,000 adults (18–64) found that one in four prescribed stimulants abused them.[6] Today, more than half (51%) of stimulant abusers are aged 26 or older.[7] According to IQVIA data, adults aged 31–40, particularly women, and older adults (41–70) saw the steepest rise in stimulant prescribing between 2012 and 2023.[8]

Psychiatric Prescribing Trends & Abuse

In 2022, psychiatrists, pediatricians, and nurse practitioners continued to be the most common prescribers of stimulants.[9] A Medical Expenditure Panel Survey (2016–2019) showed psychiatrists prescribed 33.5% of psychotropics, while general practitioners, nurse practitioners, and physician assistants combined wrote more than 60%.[10] From 2021 to 2023, stimulant marketing payments to physicians doubled from $1.8 million to $3.6 million. The increases were driven in large part by growth in marketing to psychiatrists (a 250% increase). A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to 2022.[11] Jan Eastgate, President of CCHR International, says, "IQVIA reports U.S. psychiatric drug sales have reached $25.8 billion—underscoring how prescribing and marketing incentives drive a highly lucrative business."

More on Nyenta.com
  • Why 3i Atlas? A Wonder in Heaven
  • Independent Artist Djamee Releases Groundbreaking Holiday Album "Holiday With Djamee And Me."
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • Pink Elephant Party & Tents Elevates Holiday Celebrations on Long Island
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

The long-term effects of stimulant abuse include heart attack, stroke, seizures, liver and kidney damage, arrhythmia, coma, and death. Sedatives and tranquilizers also carry high risks, including liver failure, amnesia, nightmares, vision loss, depression, and death.[12]

From 2006 to 2023, SSRI antidepressant use among children and adolescents (ages 3–17) rose from 1.5% to 3.6%. Adult prescribing has steadily increased across four major psychotropic classes.[13] The journal Pharmaceuticals warns of SSRI dependence and withdrawal, affecting 55–65% of users.[14] In 2023, SSRIs were implicated in 64,993 single-substance toxic exposures reported to U.S. poison centers, including 285 major outcomes and three fatalities. Rates of SSRI ingestion mirror rising prescription levels.[15]

Misinformation about addiction risks and the perception that prescription drugs are "safer than street drugs" help drive abuse of them.[16] Sixty-two percent of teenagers admitted to abusing prescriptions because they were easily obtained from parents' medicine cabinets, while 35% said they believed prescriptions were safer than illegal substances.[17] College initiates often misuse stimulants as "study aids," while pre-college initiates abuse them recreationally.[18]

CCHR warns that psychiatric diagnostic expansion—driven by the Diagnostic and Statistical Manual of Mental Disorders (DSM)—inflates disorder rates and fuels prescription demand. It criticizes a system in which psychiatrists with financial ties to the pharmaceutical industry vote on which disorders to include.

As Professors Herb Kutchins and Stuart A. Kirk wrote in Making Us Crazy, "DSM is used to directly affect national health policy and priorities by inflating the proportion of the population that is defined as 'mentally disordered.'"[19] These inflated figures drive mental health budgets and prescribing.

The rise of telehealth and e-prescribing, direct-to-consumer (DTC) marketing strategies and subscription-based models—enabled by DSM-based diagnoses—have fueled a surge of direct-to-consumer platforms aggressively marketing adult ADHD treatment through subscription-based models. Both the Drug Enforcement Administration and the Food and Drug Administration have raised concerns over diversion and misuse from such services.[20]

CCHR, established in 1969 by the Church of Scientology and psychiatrist Prof. Thomas Szasz, says urgent action is needed to end the aggressive marketing of psychotropic drugs and the false perception that prescriptions guarantee safety. It emphasizes that people need to be informed that no medical test can confirm a mental disorder, while recognizing that emotional distress is real and can be severe. The watchdog warns that youth, in particular, must be alerted that these drugs carry grave risks of dependence, abuse, and overdose—even when obtained legally from a doctor or psychiatrist.

More on Nyenta.com
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies
  • South Florida Real Estate BocaRealty.com & BoyntonRealty.com Updated Websites for Buyers and Seller
  • Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress

Sources:

[1] "Prevalence and risk factors for misuse of prescription psychotropic drug in patients with severe mental illness: A systematic review," Actas Esp Psiquiatr. 1 Sept. 2023, pmc.ncbi.nlm.nih.gov/articles/PMC10803847/

[2] www.cchrint.org/2023/03/10/cchr-calls-for-more-oversight-after-recent-addiction-treatment-center-closures/

[3] drugabusestatistics.org/prescription-drug-abuse-statistics/

[4] drugabusestatistics.org/prescription-drug-abuse-statistics/

[5] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/; www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/

[6] www.webmd.com/add-adhd/news/20250409/america-may-have-a-new-rx-drug-crisis-are-you-part-of-it

[7] drugabusestatistics.org/prescription-drug-abuse-statistics/

[8] "Stimulant Prescription Trends in the United States From 2012-2023," IQVIA Government Solutions, Inc., prepared for the DEA, 13 Nov 2023, pp. 4-5

[9] Ibid.

[10] Psychotropic Medication Prescribing Across Medical Providers, 2016–2019, Psychiatry OnLine, 20 Nov. 2023; www.psychiatryonline.org/doi/10.1176/appi.ps.20230156

[11] www.medpagetoday.com/pediatrics/adhd-add/117138

[12] drugabusestatistics.org/prescription-drug-abuse-statistics/

[13] "U.S. Population Prevalence of Prescription Psychiatric Medication Use Among Children and Adolescents, 2006-2023," ASPE, Office of the Assistant Secretary for Planning and Evaluation, 4 Aug. 2025, aspe.hhs.gov/reports/psychotropic-medication-among-children-adolescents

[14] "A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases," Pharmaceuticals, May 2022, pmc.ncbi.nlm.nih.gov/articles/PMC9146999/

[15] "Selective serotonin reuptake inhibitor poisoning," www.uptodate.com/contents/selective-serotonin-reuptake-inhibitor-poisoning

[16] www.ascendhc.com/teen-rehab-blog/prescription-pills-abuse/

[17] drugabusestatistics.org/prescription-drug-abuse-statistics/

[18] drugabusestatistics.org/prescription-drug-abuse-statistics/

[19] Herb Kutchins and Stuart A. Kirk, Making Us Crazy: The Psychiatric Bible and the Creation of Mental Disorders (The Free Press, New York, 1997), p. 243

[20] www.trillianthealth.com/market-research/studies/increases-in-adult-adhd-diagnosis-and-off-label-stimulant-prescribing

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights International
Filed Under: Medical, Health, Government

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Nyenta.com
  • New Book by L.S. Smith Flips the Self-Help Script with Humor, Honesty, and Heart
  • Saelig Introduces $396 AIM-TTi ATG1005 5MHz Function Generator
  • Kaplan Morrell Law Firm Represents Former NHL Player in Workers' Compensation Case Drawing National Attention
  • Local Lighting Experts Debut AI Christmas Decorator: Upload a Photo, Get Instant Professional Holiday Design-- Completely Free
  • Emergency Court Hearing on Temporary Restraining Order in Raven v. NYS DEC Thursday, November 14, — Elmira, New York
  • MBA Standards Board Marks Trustees' Week Honoring Leaders Shaping the Future of Business Education
  • Ivy On Main Brings Back Thursday Night Prix Fixe Dinner — $45 for Two Courses
  • Surf Air Mobility (N Y S E: SRFM) Accelerates Regional Air Mobility Revolution with Electra Aero Partnership, Palantir Alliance, and Record Revenue
  • Cybersecurity is Fast Becoming a Vital Issue for Protecting Personal Information and Portfolio Wealth
  • Keis To Joi Debuts "The KEIS Within Collection"
  • 10 Essential Tips for Maximizing Value When Choosing Your Orlando Wedding Venue
  • Americans Are Trading Offices for Beaches: How Business Ownership Enables the Ultimate Location Freedom
  • Boston Industrial Solutions' Natron® DC Series Ink Has Had an Upgrade!
  • Strategic Market Dynamics in Frequency Control and Timing Devices
  • Colony Ridge Proudly Supports the All Ears! 2025 Sporting Clays Tournament
  • Jacob Emrani Nominated for LA Executive Award
  • Power Funding Solutions Surpasses $100 Million in Business Funding
  • Kansas City Steak Company Shares the Return of Their Holiday Gift Box
  • Why Gravity Racing for Diecast Cars Shines at Timber Creek Speedway
  • The Icla da Silva Foundation Honors Dr. Selwyn Vickers, President and CEO of MSKCC

Popular on Nyenta

  • Hiclean Tools Releases HCX2100 Electric Pressure Washer - 104
  • Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
  • Arctic Edge Solutions LLC Secures $25,000 Revolving Credit Line from Penguin Securities
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • Wedding Bells: Newlyweds Rush to Try Simple QR Code 'Photo Hack' That's Taking the Stress Out of Wedding Memories
  • America Anesthesia Partners Unveils New User-Friendly Website
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • AGI prize for Emtech AI: replacing OpenAI
  • Mary Lee Painter Releases New Holiday Romcom Holiday on the Rocks
  • Filmmaker Christopher Wells Headlines Horrorcon: The Third Awakening

Similar on Nyenta

  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • Why 3i Atlas? A Wonder in Heaven
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • Veteran Seeks Immediate Corrective Care Under FTCA; Ninth Circuit Petition Filed to Restore Merits Forum
Copyright © 2025 nyenta.com | Terms of Service | Privacy Policy | Contribute | Contact Us